10 Jun 2026
More people are coming into primary care with concerns about memory loss. This puts primary care providers at the center of early evaluation of cognitive impairment and other potential Alzheimer's disease symptoms. In the past, limited tools meant diagnosis could be complex and delayed.
This webinar addresses:
- How recent advances in technology enable development of high-sensitivity blood tests
- Alzheimer’s disease pathology and how it relates to blood biomarkers
- The latest tools available to primary care physicians to support assessment, including the FDA-cleared Elecsys® pTau-181 blood test, pTau-217 and the Beta Amyloid 42/40 Ratio
- Why pre-test probability is critical to successfully integrating these tools in primary care workflows
Speaker:
Joseph M. Volpe, PhD